Novartis (NVS)

Add to Watchlists
Create an Alert
90.15 +0.91  +1.02% NYSE Oct 24, 8:00PM BATS Real time Currency in USD

Novartis Cash from Financing (TTM):

-9.235B for June 30, 2014

View 4,000+ financial data types

View Full Chart

Novartis Cash from Financing (TTM) Chart

Export Data
Save Image

Novartis Historical Cash from Financing (TTM) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 -9.235B
March 31, 2014 -9.116B
Dec. 31, 2013 -8.769B
Sept. 30, 2013 -8.395B
June 30, 2013 -9.12B
March 31, 2013 -8.273B
Dec. 31, 2012 -6.675B
Sept. 30, 2012 -9.751B
June 30, 2012 -11.39B
March 31, 2012 -16.28B
Dec. 31, 2011 -15.02B
Sept. 30, 2011 -14.86B
June 30, 2011 -3.90B
March 31, 2011 3.607B
Dec. 31, 2010 4.116B
Sept. 30, 2010 8.035B
June 30, 2010 1.274B
March 31, 2010 2.379B
Dec. 31, 2009 2.809B
Sept. 30, 2009 -798.00M
June 30, 2009 -556.00M
March 31, 2009 1.568B
   
Dec. 31, 2008 -2.573B
Sept. 30, 2008 -1.981B
June 30, 2008 -5.539B
March 31, 2008 -10.53B
Dec. 31, 2007 -9.318B
Sept. 30, 2007 -8.065B
June 30, 2007 -5.667B
March 31, 2007 -5.662B
Dec. 31, 2006 -4.931B
Sept. 30, 2006 -1.232B
June 30, 2006 -1.354B
March 31, 2006 1.097B
Dec. 31, 2005 -271.00M
Sept. 30, 2005 -1.208B
June 30, 2005 -1.476B
March 31, 2005 -3.862B
Dec. 31, 2004 -2.998B
Sept. 30, 2004 -4.413B
June 30, 2004 -4.427B
March 31, 2004 -6.277B
Dec. 31, 2003 -5.732B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Get data for
Advertisement

NVS Cash from Financing (TTM) Benchmarks

Companies
GlaxoSmithKline -8.811B
Eli Lilly -2.863B
Roche Holding

NVS Cash from Financing (TTM) Range, Past 5 Years

Minimum -16.28B Mar 2012
Maximum 8.035B Sep 2010
Average -5.714B

NVS Cash from Financing (TTM) Excel Add-In Codes

  • Metric Code: cash_financing_ttm
  • Latest data point: =YCP("NVS", "cash_financing_ttm")
  • Last 5 data points: =YCS("NVS", "cash_financing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.